CD138 mRNA expression from peripheral blood of patients with follicular and diffuse large B cell lymphoma: relation to disease progression and treatment response-Reference-Cited by-同舟云学术

CD138 mRNA expression from peripheral blood of patients with follicular and diffuse large B cell lymphoma: relation to disease progression and treatment response

Published:2013-02-23 Issue:4 Volume:23 Page:855-859
ISSN:1618-5641
Container-title:Comparative Clinical Pathology
language:en
Short-container-title:Comp Clin Pathol

Author:

Abd elmohsen Soheir Elsaid,Attia Fadia M.,Elbahie Hossam M.,Enany Maha M.,Mohamed Doaa

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine,Anatomy

Link

http://link.springer.com/content/pdf/10.1007/s00580-013-1703-y.pdf

Reference21 articles.

1. Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge SC, Bernfield M (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Gen 25:329–332

2. Bayer-Garner IB, Sanderson RD, Dhodapkar MV et al (2001) Syndecan-1 cd138; immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions. Mod Pathol 14:1052–1058

3. Blackhall FH, Merry CLR, Davies EJ, Jayson GC (2001) Heparan sulfate proteoglycans and cancer. Br J Cancer 85:1094–1098

4. Carbone A, Gloghini A, Gattei V, Degan M, Improta S, Aldinucci D, Canzonieri V, Perin T, Volpe R, Gaidano G, Zagonel V, Pinto A (1997) Reed-Sternberg cells of classical Hodgkin’s disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1. Blood 89:3787–3794

5. Fujiya M, Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y (2001) Reduced expression of syndeca1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res 92:1078–1081